{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:59:49Z","timestamp":1783713589117,"version":"3.55.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:p>Methamphetamine (METH) use and dependence is a serious public health concern with implications across multiple areas from societal impact to burden on psychiatric and medical resources. An estimated 8% of admissions to substance abuse treatment programs are related to stimulants with METH\/amphetamine abuse. To date, effective pharmacotherapy options to enhance abstinence have not been identified. The objective of this article is to critically review the literature of METH treatment options. Preclinical research and human research with compounds not yet available commercially in the United States will not be included. A literature review was conducted for research on pharmacological treatments for METH use and addiction. Trial information on the use of sertraline, bupropion, mirtazapine, modafinil, dextroamphetamine, ondansetron, risperidone, aripiprazole, baclofen, and gabapentin was reviewed. Aripiprazole trials appeared in the reviewed literature more frequently than the other medications. Based on the findings of this review, no single medication demonstrated consistent efficacy and each trial contained a variety of methodological limitations.<\/jats:p>","DOI":"10.1177\/0897190011426557","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T02:20:24Z","timestamp":1321582824000},"page":"541-550","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":63,"title":["Treatments for Methamphetamine Abuse"],"prefix":"10.1177","volume":"24","author":[{"given":"Todd","family":"Brackins","sequence":"first","affiliation":[{"name":"Pharmacy Practice, Harding University College of Pharmacy, Searcy, AR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy C.","family":"Brahm","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences\u2014Tulsa, University of Oklahoma College of Pharmacy, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Kissack","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, Harding University College of Pharmacy, Searcy, AR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"bibr1-0897190011426557","unstructured":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Methamphetamine Use. January 26, 2007; Rockville, MD."},{"key":"bibr2-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e318160e1db"},{"key":"bibr3-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198805053181806"},{"key":"bibr4-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(09)85003-4"},{"key":"bibr5-0897190011426557","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3565(24)38814-7","volume":"296","author":"Brown JM","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr6-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1515\/bc.2011.016"},{"key":"bibr7-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-009-9024-2"},{"key":"bibr8-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007812"},{"key":"bibr9-0897190011426557","first-page":"2009","volume":"329631","author":"Kerdsan W","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"bibr10-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06688.x"},{"key":"bibr11-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2002.10399967"},{"key":"bibr12-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.03.005"},{"key":"bibr13-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.010"},{"key":"bibr14-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301481"},{"key":"bibr15-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300979"},{"key":"bibr16-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801935672"},{"key":"bibr17-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.12.003"},{"key":"bibr18-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.11.023"},{"key":"bibr19-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02437.x"},{"key":"bibr20-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02717.x"},{"key":"bibr21-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.307"},{"key":"bibr22-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145707007778"},{"key":"bibr23-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2007.10399875"},{"key":"bibr24-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300803"},{"key":"bibr25-0897190011426557","unstructured":"Package insert. Abilify (aripiprazole). Tokyo, Japan: Otsuka Pharmaceutical Co, Ltd, November 2009."},{"key":"bibr26-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.14.4.413"},{"key":"bibr27-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.004"},{"key":"bibr28-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.1.160"},{"key":"bibr29-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009097"},{"key":"bibr30-0897190011426557","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.03.019"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190011426557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190011426557","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190011426557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:34:37Z","timestamp":1777509277000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190011426557"}},"subtitle":["A Literature Review for the Clinician"],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1177\/0897190011426557"],"URL":"https:\/\/doi.org\/10.1177\/0897190011426557","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}